- A four-million year-old strain of Paenibacillus isolated from soil samples in Lechuguilla Cave was found to be naturally resistant to daptomycin.[21].
- Some recent studies have compared daptomycin used for the treatment of vancomycin-resistant enterococcus bacteremia.
- Daptomycin (CAS NO.103060-53-3) was originally discovered by researchers at Eli Lilly and Company in the 1980s, who designated the compound LY 146032.
- Daptomycin is indicated for the treatment of complicated skin and skin structure infections (cSSSI) in patients one year of age and older.
- Daptomycin is an antibiotic that is used in adults and children at least 1 years old to treat complicated bacterial infections of the heart, skin, or blood.
- Diğer Antibakteriyeller. Diğerleri. Daptomycin. Barkodu
- Medscape - Infection dosing for Cubicin (daptomycin), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation...
- Daptomycin has linear pharmacokinetics at doses of 0.5–6 mg/kg, but in 20% of adults given 8 mg/kg intravenously there is non-linear accumulation.
- Daptomycin is an antibiotic that is used in adults and children at least 1 years old to treat complicated bacterial infections of the heart, skin, or blood.
- Animal reproduction studies with daptomycin have not shown risk to the fetus, and data related to pregnancy in humans are limited to case reports.
Daptomisin
Genel bilgiler
Bir lipopeptit antibiyotiğidir. Streptomyces roseosporus isimli bakteri tarafından üretilir. Özellikle metisilin dirençli Staphylococcus aureus ve glikopeptit dirençli Enterococci karşısında çok etkilidir.
Vikipedi